Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/37520
Title: The Selective Sphingosine-1-Phosphate Receptor 1 (S1P1) Modulator Ponesimod Enhances Murine Oligodendrocyte Precursor Cell (OPC) Differentiation and Retains OPC Migration
Authors: Ait-Tihyaty, M.
PICCART, Elisabeth 
SCHEPERS, Melissa 
WILLEMS, E
DiBernardo, A.
VANMIERLO, Tim 
Issue Date: 2022
Publisher: SAGE PUBLICATIONS LTD
Source: Multiple Sclerosis Journal, 28 (S1) , p. 110
Abstract: Methods: Reversible, blue light (BL) stimulated, optogenetic A1 protein expression plasmids, containing wild-type A1, tagged with both the optogene Cryptochrome 2 and mCherry, were trans-fected into HEK293T cells and a differentiated neuronal cell line and used to examine the effects of RNA oligo treatment on protein dynamics and downstream cellular pathway functions in real-time. Using this in vitro optogenetic paradigm of A1 dysfunction, we gathered evidence on how RNA oligo treatment affects A1 self-association clustering and downstream neuronal morphology and viability. Results: Imitating an acute environmental cell stress using a BL stimulus followed by a steady period of recovery, our data show that RNA oligo treatment significantly decreased the kinetics of cytoplasmic A1 cluster formation [half-maximal formation time (minutes): Oligo=100; no treatment (NT)=62] and significantly decreased the number of cells with A1 clustering (percent cells w/ A1 clusters: Oligo=33%; NT=50%). We found that RNA oligo treatment stabilized the structure of A1 upon binding (avg. protein denaturation temp.: Oligo=62°C; NT=61°C), and significantly increased the quantity of A1 clusters (avg. clusters/cell: Oligo=19 ; NT=5) and decreased their size (avg. cluster size (µm2): Oligo=0.31; NT=0.95). Finally, we show that neuron morphology and viability were perturbed with A1 cluster formation. Conclusions: Using an in vitro optogenetic approach, this study presents evidence that A1 clustering negatively affects neuronal morphology, and that RNA oligo treatment attenuates MS-associated A1 dysfunction, indicating that A1 protein dys-function perturbation may affect NDG in MS. Background: Sphingosine-1-phosphate receptor (S1PR) modu-lators are clinically applied to target relapse remitting multiple sclerosis (MS) and the early phase of progressive MS when inflammation still prevails. S1P1 receptor modulation (functional antagonism) is known to prevent lymphocytes egression from lymph nodes, hence hampering neuroinflammation in MS. Recent findings suggest a potential additional role for S1P1 receptor modulation in neuroprotection and remyelination. Objectives: As the Giα-coupled S1P1 is the most prominently expressed S1P receptor in oligodendrocyte precursor cells (OPCs), we hypothesized that functional antagonism by the S1P1-monoselective modulator ponesimod induces OPC differentiation. Methods: Primary mouse OPCs were harvested via the shake-off method and treated in vitro with the S1P1-selective modulator ponesimod (3nM-3000nM), the S1P5-selective modulator A971432 (3nM-3000nM) or a phosphorylated form of the non-selective modulator fingolimod (3000nM). Migration was
Document URI: http://hdl.handle.net/1942/37520
ISSN: 1352-4585
e-ISSN: 1477-0970
ISI #: WOS:000796572500227
Category: M
Type: Journal Contribution
Appears in Collections:Research publications

Files in This Item:
File Description SizeFormat 
The Selective Sphingosine-1-Phosphate Receptor.pdfPublished version56.84 kBAdobe PDFView/Open
Show full item record

WEB OF SCIENCETM
Citations

1
checked on Mar 23, 2024

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.